Research Calls I
-
Upgrades
- Alignment Healthcare (ALHC) upgraded to Overweight from Sector Weight at KeyBanc, tgt $21
- Alaska Air (ALK) upgraded to Outperform from Market Perform at Raymond James, tgt $70
- Dyne Therapeutics (DYN) upgraded to Strong Buy from Outperform at Raymond James, tgt $35
- Fabrinet (FN) upgraded to Overweight from Neutral at JPMorgan, tgt $345
- FirstEnergy (FE) upgraded to Overweight from Equal Weight at Barclays, tgt $49
- Lazard (LAZ) upgraded to Outperform from Market Perform at Keefe Bruyette, tgt $65
- Okta (OKTA) upgraded to Buy from Hold at Truist, tgt $125
- Olaplex (OLPX) upgraded to Buy from Hold at Canaccord, tgt $2
- Venture Global (VG) upgraded to Buy from Neutral at UBS, tgt $18
- Alignment Healthcare (ALHC) upgraded to Overweight from Sector Weight at KeyBanc, tgt $21
-
Downgrades
- American Airlines (AAL) downgraded to Market Perform from Outperform at Raymond James
- American Eagle (AEO) downgraded to Underperform from Neutral at BofA Securities, tgt $10
- Golar LNG (GLNG) downgraded to Neutral from Buy at B. Riley, tgt $44.50
- Quest Diagnostics (DGX) downgraded to Neutral from Outperform at Robert W. Baird, tgt $194
- SentinelOne (S) downgraded to Neutral from Buy at BTIG Research
- Symbotic (SYM) downgraded to Neutral from Buy at DA Davidson, tgt $47
- American Airlines (AAL) downgraded to Market Perform from Outperform at Raymond James
-
Others
- Ambiq Micro (AMBQ) initiated with a Neutral at BofA Securities, tgt $42
- Ambiq Micro (AMBQ) initiated with a Buy at Needham, tgt $48
- Ambiq Micro (AMBQ) initiated with a Buy at Stifel, tgt $45
- Ambiq Micro (AMBQ) initiated with a Neutral at UBS, tgt $40
- Argenx (ARGX) initiated with an Outperform at RBC Capital, tgt $850
- Crescent Biopharma (CBIO) initiated with a Buy at Jefferies, tgt $26
- Civitas Resources (CIVI) initiated with a Market Perform at William Blair
- Crescent Energy (CRGY) initiated with an Outperform at William Blair
- Cue Biopharma (CUE) initiated with a Buy at Lucid Capital, tgt $4
- Journey Medical (DERM) initiated with a Buy at H.C. Wainwright, tgt $13
- Devon Energy (DVN) initiated with an Outperform at William Blair
- Diamondback Energy (FANG) initiated with an Outperform at William Blair
- Figma (FIG) initiated with a Buy at BofA Securities, tgt $85
- Figma (FIG) initiated with an Equal Weight at Wells Fargo, tgt $82
- Figma (FIG) initiated with an Outperform at William Blair
- Figma (FIG) initiated with a Peer Perform at Wolfe Research
- Figma (FIG) initiated with a Neutral at JPMorgan, tgt $65
- Figma (FIG) initiated with a Sector Perform at RBC Capital, tgt $75
- Figma (FIG) initiated with an Equal Weight at Morgan Stanley, tgt $80
- Figma (FIG) initiated with a Neutral at Goldman, tgt $48
- Gates Industrial (GTES) initiated with an Overweight at JPMorgan, tgt $35
- Magnolia Oil & Gas (MGY) initiated with an Outperform at William Blair
- Mach Natural Resources (MNR) initiated with an Outperform at William Blair
- Matador (MTDR) initiated with an Outperform at William Blair
- NewAmsterdam Pharma (NAMS) initiated with an Overweight at Wells Fargo, tgt $45
- Northern Oil and Gas (NOG) initiated with an Outperform at William Blair
- Permian Resources (PR) initiated with an Outperform at William Blair
- Shoulder Innovations (SI) initiated with a Buy at Jefferies, tgt $19
- Shoulder Innovations (SI) initiated with a Buy at BTIG Research; tgt $23
- Shoulder Innovations (SI) initiated with an Overweight at Morgan Stanley; tgt $18
- Shoulder Innovations (SI) initiated with an Overweight at Piper Sandler, tgt $18
- Shoulder Innovations (SI) initiated with a Buy at Goldman, tgt $20
- Viper Energy (VNOM) initiated with an Outperform at William Blair
- Ambiq Micro (AMBQ) initiated with a Neutral at BofA Securities, tgt $42